Parkinson's disease (PD) is a neurodegenerative disorder that predominantly affects dopamine-producing neurons in the substantia nigra, a region of the brain. It is the second most common neurodegenerative disorder after Alzheimer's disease, impacting millions worldwide. This article aims to provide a comprehensive overview of PD for healthcare professionals.
The exact cause of PD is unknown, but it is thought to result from a complex interplay of genetic and environmental factors. The hallmark pathological feature is the loss of dopaminergic neurons in the substantia nigra pars compacta, leading to striatal dopamine deficiency. This results in motor symptoms such as bradykinesia, rigidity, and resting tremor.
PD typically presents in the sixth decade of life or later. The cardinal motor symptoms are resting tremor, bradykinesia, and rigidity. Non-motor symptoms such as autonomic dysfunction, cognitive impairment, and mood disorders often precede the motor symptoms and can significantly impact quality of life.
There is no definitive diagnostic test for PD. Diagnosis is primarily clinical, based on history and neurological examination. Imaging, such as DaTscan, can support the diagnosis. Management of PD is symptomatic, with levodopa being the most effective medication for motor symptoms. Non-pharmacological interventions, including physical therapy and exercise, also play a crucial role.
PD is a progressive disorder. The rate of progression varies widely among individuals. Factors associated with faster progression include older age at onset, presence of postural instability and gait difficulty, and cognitive impairment. Despite advances in treatment, PD remains a leading cause of disability.
Understanding the complexities of Parkinson's disease is crucial for healthcare professionals. As we continue to unravel the mysteries of this disorder, we can hope to improve diagnosis, management, and ultimately, patient outcomes. Continued research and education are key to achieving these goals.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation